Studying Prescription Monitoring Program Impacts in a Community Psychiatry Practice-Based Research Network

Similar documents
5/26/2016. What is a PBRN? PBRN Resource Center. Resource Center for PBRNs. Resource Center for PBRNs. Active PBRNs. Practice-Based Research Networks

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018

Applying Population Health Management to Opiate Prescription Medication Misuse

Although PDMPs are separately managed and maintained by each state or jurisdiction, the national network facilitates more uniformity among states.

Safe States Alliance 2018 Innovative Initiatives Finalist Summaries for Review

is rarely visible, and communication about use of opioids for chronic pain patients is ad hoc and informal.

Opioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative

Opioid epidemic and PEHP

The Epidemiology of Opioid Abuse Thomas Dobbs, MD, MPH 6/30/2017

Shawn A. Ryan, MD, MBA Assistant Professor, Dept. of Emergency Medicine, University of Cincinnati Chair of Quality & Patient Safety, Jewish

Implementing Pain and Opioid Management Guidelines in Primary Care Practice

Addressing the Opioid Epidemic in Tennessee

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Review of Controlled Drugs and Substances Act

NARxCHECK Score as a Predictor of Unintentional Overdose Death

MANAGING PAIN WHILE MINIMIZING RISK OF SUBSTANCE USE DISORDER OUTLINE. EPIDEMIC / CRISIS The Epidemic / Crisis Around Opioid Prescription Use

Opioid Report Card. opioid oversight from MN Dept of Health

Best Practices in Prescribing Benzodiazepines. Michael Carlisle, DO Medical Director University Hospitals Geauga Medical Center

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

How to Integrate Peer Support & Navigation into Care Delivery

Public Health Masters (MPH) Competencies and Coursework by Major

COMPUS Vol 2, Issue 8 December 2008

Vanila M Singh, MD MACM Chief Medical Officer Office of the Assistant Secretary for Health U.S. Department of Health and Human Services

State Action to Prevent and

PRESCRIBING GUIDELINES

South Texas Psychiatric Practice-Based Research Network Meeting March 10th, 2010

DUPLICATION DISTRIBUTION PROHIBBITED AND. Utilizing Economic and Clinical Outcomes to Eliminate Health Disparities and Improve Health Equity

Arkansas Prescription Monitoring Program

Jerry Cochran, MSW, PhD University of Utah School of Medicine Department of Internal Medicine Department of Psychiatry

Addressing the Opioid Crisis An ACH Collaboration

Rationale for creating a PBRN in chiropractic. Cheryl Hawk, DC, PhD Associate Vice President of Research and Health Policy

PA Opioid Overdose Reduction Technical Assistance Center

The Opioid Crisis Made in America Fade in America?

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Opioid Prescribing Improvement Program

Morrison County Community-Based Care Coordination. Our Core Values Reverence Integrity Compassion Excellence

Michigan Legislative and Regulatory Pharmacy Initiatives Update

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Data-Driven Prevention Initiative

Prescription Drug Monitoring Programs and Other State-Level Strategies

Progress from the Patient-Centered Outcomes Research Institute (PCORI)

Presentation Objectives

Recommendations in Opioid Prescribing Guidelines for Chronic Pain

Opioid Initiative Wave I PDMPs and Screening

This evaluation was funded by the Centers for Disease Control and Prevention

PREVENTING PRESCRIPTION DRUG ABUSE AND OVERDOSE JUNE 23, 2016 SHERRY L. GREEN

Community Pharmacy-based Immunization

Arkansas Prescription Monitoring Program

Greenbrier County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Patient Involvement in Pharmacovigilance: The Development of an HIV Peer Educator Program

Stage 3 Psychotherapies EPAs & COE forms

Quality and Fiscal Metrics: What Proves Success?

Opioids drive continued increase in drug overdose deaths

State, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.

Taos Alive. Improving a Community in Pain By Julie Martinez CPS

OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC:

University of Pittsburgh

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

The Epidemiology of Opioid Abuse. Thomas Dobbs, MD, MPH Mississippi State Department of Health

Queen s Family Medicine PGY3 CARE OF THE ELDERLY PROGRAM

An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder

DRUG OVERDOSE DEATHS ANALYSIS

Six Building Blocks Self-Assessment Questionnaire Workshop Version July 2017

Table of Contents Interim Report of the OxyContin Task Force, Newfoundland & Labrador, January 30, 2004

Mixed Methods in Implementation Research Lawrence A. Palinkas, PhD. Albert G. and Frances Lomas Feldman Professor of Social Policy and Health

Public Policy and Best Practices for Reducing Opioid Harm. State Capital Building, Harrisburg PA June 6, 2018

Presenters: Robin Newhouse Steven Goodman David Hickam

Opioid Initiative Wave I Starting an ALTO Program

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Pain: Assessment, Non-Opioid Treatment Approaches and Opioid Management

Barbour County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report Barbour County

The Integrative Pain Management Program: A Pilot Clinic Serving High-Risk Primary Care Patients with Chronic Pain

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

Global Bridges and Pfizer Independent Grants for Learning & Change (IGLC)

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County

Mindful Prescribing for Acute Pain

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC

Organizational HIV Treatment Cascade Guidance for Construction. Introduction. Background

Implementation: Public Hearing: Request for Comments (FDA-2017-N-6502)

Upon completion of residency training, Psychiatrists will have developed a range of specific competencies in multiple domains described as follows:

using analytics to identify and strategically manage patient opioid abuse

Reducing Opioid Over- Prescribing in a Large Integrated Health Care System

Mingo County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

Opioid Crisis: HHS Strategy and Advancing Pain Management

Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD

Putnam County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Policy and Political Dynamics of the Opioid Addiction Crisis in the United States

Attitudes Toward Medication-Assisted Treatment Within a Drug Court Program. Caroline Allison. Dr. Kathleen Moore, Ph.D.

A Cochrane systematic review of interventions to improve hearing aid use

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

ROYAL COLLEGE OF PSYCHIATRISTS RAPID EVIDENCE REVIEW OF EVIDENCE-BASED TREATMENT FOR GAMBLING DISORDER IN BRITAIN

Pocahontas County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Kanawha County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Collaborative Assessment and Management of Suicidality (CAMS)

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES

Transcription:

Studying Prescription Monitoring Program Impacts in a Community Psychiatry Practice-Based Research Network A UNIVERSITY HOSPITALS/CWRU DEPARTMENT OF PSYCHIATRY INITIATIVE IN COLLABORATION WITH THE CWRU PBRN SHARED RESOURCE TEAM AND THE CLINICAL AND TRANSLATIONAL SCIENCE COLLABORATIVE OF CLEVELAND ANDREW HUNT, MD, MHA, KATHLEEN CLEGG, MD, FARAH MUNIR, MD INSTITUTE FOR PSYCHIATRIC SERVICES 2016

Objectives 1. Describe the possible uses of Practice-Based Research Networks (PBRNs) in Community Psychiatry 2. Create and develop research questions pertaining to the potential impacts of Prescription Monitoring Programs (PMPs) on community-based psychiatric prescribers. 3. Identify the steps in implementing a Card Study Protocol in a Community Psychiatric Practice-Based Research Network.

Introduction: Agenda I. Background PBRN PMP Monitoring II. Developing a Research Question Research Question Activity III. Choosing Methodology What is a Card Study? Card Development Activity IV. Participating in Practice-Based Research Card Completion Activity V. Results and Lessons Learned

Background: What is a PBRN? Practice Based Research Network Collaborations of practice settings that work together to generate research knowledge

Background: What is a PMP? Prescription Monitoring Programs (PMPs) are registries that record patient, pharmacy, prescription drug, and prescriber data in order to inform practitioners about their patients recent acquisitions of controlled substances Prescription Drug Monitoring has become a priority with increasing awareness of prescription drug misuse, diversion, and associated mortality State laws differ widely with regard to PMPs

Background: What is a PMP? Observational Studies and Surveys support PMP s effectiveness PMP s have reported precipitous decreases in several states in Doctor Shopping. Preliminary CDC data has indicated a decrease in opioid analgesic deaths. Impacts on Prescriber behavior have not been studied extensively

Background: PMPs across the nation

Background: What is OARRS? Begun in 2007 Mandated Checks starting in 2015 Delegation of OARRS database checks allowed to MAs

Background: Effects of OARRS in Ohio(2012-2015) Total doses of opioids decreased by 92 million doses (11.6%) Total doses of benzodiazepines decreased by 22 million doses (7.4%) Doctor Shopping decreased 71% between 2010 and 2015.

Background: Effects of OARRS in Ohio Q1 2016 Cuyahoga County -0.45 per capita Q1 2010

Background: Effects of OARRS in Ohio Benzodiazepine Prescriptions Opioid Prescriptions

Background: Effects of OARRS in Ohio Benzodiazepine Prescriptions Doctor Shopping OARRS Queries

Why Study PMPs in Community Psychiatry? Study real life clinical problems Methods require minimum time commitment from any clinician Rapid cycle between data collection and changing practice Many methodologies possible

Developing a Research Question Good Research Relevant Rapid and Recursive Redefines Rigor Resource Sensitive Replicable

Developing a Research Question Must be a Question (not a statement) Must be Relevant to Clinicians Must address a Problem Must address a Gap in Knowledge Must consider Stakeholders

Research Question Activity: What questions should we study? In groups of 3, create a research question related to PMP that meets the following criteria: 1. Question 2. Relevant 3. Addresses a Problem 4. Addresses a Gap in Knowledge 5. Considers Stakeholders

Choosing Methodology Based on Research Question Quantitative Qualitative Based on Resources Funding Personnel Based on Stakeholders Feasible from all perspectives Solves problems for stakeholders Relevance

Choosing Methodology Psychiatric PBRN Methods Surveys Qualitative Interviews and Focus Groups Observation of Actual Practice (Card Studies) Chart Review Clinical Trials System Quality Improvement Trials Implementation Science Participatory Action Research

Methodology: What is a Card Study? An observational study that collects patient-level survey data at the point-of-care Have been used in primary care settings for more than 30 years Can be used to study specific conditions or care (clinician completes card when encounters a patient who meets inclusion criteria) OR Can be used to determine trends and prevalence of conditions (clinician completes a card on all patients seen during a specified time period)

Card Development Activity: What questions should be on the Survey/Card? In small groups, you will each be given a component of the card to complete Provider Survey Patient Characteristics OARRS Report Characteristics Prescriber Decision Making

BRAIN OARRS Survey

BRAIN OARRS Card

BRAIN OARRS CARD

Participating in Practice-Based Research Roles Organizational Core Committee Membership Practice Facilitator Stakeholder Data Analysis Dissemination

Card Completion Activity: The Clinician Experience 4 OARRS reports and clinical cases to be distributed to participants Work individually to fill out the OARRS card study based on the clinical case and OARRS report you have just reviewed

Card Completion Activity: Gathering Feedback What stood out to you about the OARRS report you reviewed? Do you think the information on this OARRS report would change you decision making about prescribing for this patent? If so, how? Other feedback?

Dissemination: Results - Providers Providers enrolled were a diverse mixture of race/ethnicity, age, and gender, but with a majority of white and Asian providers. Included APNs, MDs, and Trainees, representing the diversity of prescriber types at Cleveland CMHCs.

Dissemination: Results Provider Attitudes Most providers are satisfied both categorically and in general with OARRS in their clinical practice. General Satisfaction was correlated with positive responses in all categories except views that OARRS is an encumbrance. Encumbrance ratings were not correlated with any specific provider characteristics.

Dissemination: Patient Characteristics The most common demographics were white, female, and enrolled in treatment for equal or longer than 1 year. Longer Treatment Duration was common Treatment adherence was estimated to be prevalent

Dissemination: Patient Diagnoses The most common comorbid diagnoses were depression and anxiety, although comorbidity was prevalent in 70% of cases. A significant minority had comorbid addiction diagnoses, and chronic pain. Chronic Pain was correlated with 36% of patients, and with opioid prescription.

Dissemination: OARRS Red Flags Red Flags were reported in 22%(n=40) of OARRS reports. This rate was previously unknown in outpatient samples, and the modal number of flags per provider was 1 out of 8 encounters.

Dissemination: OARRS Red Flags Providers discussed Red Flags with their patients frequently, and they reported wanting to check OARRS more often when Red Flags were present. Multiple prescribers and pharmacies were the most common red flags reported. In 40% of encounters, providers found OARRS important or extremely important to their decision-making. This attitude was significantly correlated with Red Flags.

Dissemination: OARRS Red Flags

Dissemination: OARRS Prescribing

Dissemination: Results and Lessons Learned

Pending Secondary Analyses Hypothesis: Red Flag's are correlated with decreased/discontinued prescriptions Hypothesis: Some patient characteristics (Dx, Non-adherence, short Length of treatment) are correlated with more frequent discretionary OARRS checks Hypothesis: Provider/Patient characteristics (demographic, attitudes) are correlated with frequency of red flags Hypothesis: Provider/Patient characteristics (demographic, attitudes) are correlated with more frequent discretionary OARRS checks

Dissemination: Lessons Learned Key Findings Broad Applicability: The mandated utilization of the OARRS PMP has affected the practice of all prescribers in the state of Ohio. First study of psychiatric prescribers mandated use of OARRS. OARRS is an acceptable and useful tool, which often reveals new information that affects clinical decisionmaking. Psychiatric prescribers at Cleveland-area CMHCs use OARRS more frequently than mandated, likely due to its utility.

Dissemination: Lessons Learned Key FIndings Although some prescribers find it burdensome, almost all prescribers at Cleveland-area CMHCs are satisfied with its impact, regardless of demographics. Although there was some indication that more senior prescribers found OARRS implementation more burdensome, this may reflect fatigue with respect to electronic medical records, and more documentation requirements. Included APNs and trainees more accurately represents the current population of prescribers than Psychiatrist-only studies.

Dissemination: Lessons Learned With respect to Red Flags: Red Flags in OARRS reports clearly impact provider prescription behavior, attitudes, and interactions with patients. Frequency of red flags is only 20% in a diverse community sample. Further, some providers may have lower rates of Red Flags, perhaps related to the prevalence of addiction in the population they serve. Future research will require more prescribers, and more encounter cards per provider in order to correlate Red Flags with patient/prescriber characteristics. While Red Flags affect clinical practice significantly, providers use their clinical judgment differentially with respect to red flags, balanced with other patient and illness characteristics.

Feedback: What about PBRNs in Psych?